Eulàlia Olesti

5PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targetsCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.

Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés

|Mar 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta

|Jan 03, 2024
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer.

Hélène Poinot, Eloïse Dupuychaffray, Grégoire Arnoux

|Jan 18, 2020
LC-MS/MS method for the quantification of new psychoactive substances and evaluation of their urinary detection in humans for doping control analysis.

Eulalia Olesti, Jose Antonio Pascual, Mireia Ventura

|Nov 20, 2018
Metabolomics predicts the pharmacological profile of new psychoactive substances.

Eulàlia Olesti, Ilario De Toma, Johannes G Ramaekers

Pageof 1

Frequent Collaborators

2 joint publications

Valentín Cabañas

2 joint publications

Luis Gerardo Rodríguez-Lobato

2 joint publications

Lucía López-Corral

2 joint publications

Juan Luis Reguera-Ortega